CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

norovirus bivalent vlp vaccine

Vaccineexperimental

Clinical trial activity

8 trials · 10 clinical orgs · 0 marketing orgs

Phase 1
5
Phase 2
5
Phase 3
0
Phase 4
0

Earliest trial started Nov 1, 2008 (NCT00806962)

Timeline

2000s

  1. Jan 1, 2008

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2014

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

  • NorovirusImmunity, active

    immunity, active - norovirus

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • bivalent norovirus vaccine
  • norovirus bivalent vlp vaccine
  • norovirus gi.1/gii.4 bivalent vlp vaccine
  • norwalk virus-like particle
  • norwalk vlp vaccine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05508178Phase 1Aug 17, 2020Ghent University, Icon Genetics
NCT02661490Phase 2Feb 1, 2016Takeda
NCT02142504Phase 2May 1, 2014Takeda
NCT02038907Phase 2Mar 1, 2014Takeda
NCT01609257Phase 1/Phase 2 (Phase 2)Jul 1, 2012Baylor University, Emory University, Shin Nippon Biomedical Laboratories, Takeda, University of Cincinnati, University of Rochester
NCT01168401Phase 1Sep 1, 2010Takeda
NCT00973284Phase 1/Phase 2 (Phase 2)Aug 4, 2009Baylor University, Johns Hopkins University, Shin Nippon Biomedical Laboratories, Takeda, University of Cincinnati
NCT00806962Phase 1Nov 1, 2008LigoCyte, University of Rochester
Showing 8 of 8 trials
Page 1 / 1

Organizations

Research & Development (10)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
TakedaFor profit6622009
Baylor UniversityAcademic/Hospital2012009
Shin Nippon Biomedical LaboratoriesFor profit2012009
University of CincinnatiAcademic/Hospital2012009
University of RochesterAcademic/Hospital2022008
Emory UniversityAcademic/Hospital1012012
Ghent UniversityAcademic/Hospital1012020
Icon GeneticsFor profit1112020
Johns Hopkins UniversityAcademic/Hospital1012009
LigoCyteFor profit1112008
10 organizations
Page 1 / 1